» Articles » PMID: 34034548

Pathogenesis and Characteristics of Large Ameloblastoma of the Jaw: a Report of Two Rare Cases

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2021 May 26
PMID 34034548
Authors
Affiliations
Soon will be listed here.
Abstract

Ameloblastoma is a common odontogenic epithelial tumor that exhibits various biological behaviors, ranging from simple cystic expansion to aggressive solid masses characterized by local invasiveness, a high risk of recurrence, and even malignant transformation. We report on two cases of unusually large solid ameloblastomas. We detected epithelial-mesenchymal transition-related gene expression and gene single nucleotide polymorphisms, providing possible molecular evidence of mesenchymal morphological changes in ameloblastoma. The detailed analysis of the pathogenesis of these two cases of ameloblastoma may deepen our understanding of this rare disease and offer promising targets for future targeted therapy.

References
1.
Mukhopadhyay S, Raha K, Mondal S . Huge ameloblastoma of jaw-A case report. Indian J Otolaryngol Head Neck Surg. 2012; 57(3):247-8. PMC: 3451340. DOI: 10.1007/BF03008023. View

2.
Lyu H, Li M, Jiang Z, Liu Z, Wang X . Correlate the Mutation and the Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer. Comput Struct Biotechnol J. 2019; 17:1020-1030. PMC: 6695281. DOI: 10.1016/j.csbj.2019.07.009. View

3.
Qiu X, Hu D, Chen W, Chen R, Qian S, Li C . PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(5 Pt A):1754-1769. DOI: 10.1016/j.bbadis.2018.03.002. View

4.
Myers M, Banda M, McKim K, Wang Y, Powell M, Parsons B . Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas. Neoplasia. 2016; 18(4):253-63. PMC: 4840288. DOI: 10.1016/j.neo.2016.03.002. View

5.
Castillo-Martin M, Collazo Lorduy A, Gladoun N, Hyun G, Cordon-Cardo C . H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases. J Pediatr Urol. 2015; 12(2):91.e1-7. DOI: 10.1016/j.jpurol.2015.08.020. View